19 June 2013
Keywords: allergan, licenses, polyphor, pem, drugs, 61m, deal
Article | 10 November 2008
Privately-held Swiss firm Polyphor has licensed the rights to develop Protein Epitope Mimetics cytokine inhibitors for conditions and
diseases of ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
10 November 2008
15 December 2008
22 September 2008
© 2013 thepharmaletter.com